Jian Su

Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang et al. · Clinical Cancer Research · 2016 · 992 citations

Medicine, Immunology, Oncology +17

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

Zhong‐Yi Dong, Jia‐Tao Zhang, Si‐Yang Maggie Liu et al. · OncoImmunology · 2017 · 445 citations · Full text

Life Sciences, Immunology, Oncology +17

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

Qing Lan, Chao A. Hsiung, Keitaro Matsuo et al. · Nature Genetics · 2012 · 354 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy

Y.S. Li, Bo Jiang, Jin‐Ji Yang et al. · Annals of Oncology · 2018 · 330 citations · Full text

Medicine, Genetics, Oncology +17

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou et al. · EBioMedicine · 2020 · 251 citations · Full text

Medicine, Molecular Biology, Oncology +17